Analyst Ratings for Oxygen Biotherapeutics (OXBT)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/13/2014 | Ladenburg Thalmann | N/A | New Coverage | Buy (N/A) |
10.50 (N/A) |
7.35 (4.04) |
-45.03% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/13/2014 | Ladenburg Thalmann | N/A | New Coverage | Buy (N/A) |
10.50 (N/A) |
7.35 (4.04) |
-45.03% | Details |